Skip to content
Precision for Medicine
false false
false
Blog

The Precision Blog

100% sourced from leading minds on the front lines of research

Recent and Featured Posts

View all articles
  • Clinical Research Insights

    All Clinical Research Articles
    • Read: Phase 1 Clinical Trial Designs Explained: BOIN, CRM, BLRM & Modern Adaptive Strategies Phase 1 Clinical Trial Designs Explained: BOIN, CRM, BLRM & Modern Adaptive Strategies

      Clinical Trials

      Phase 1 Clinical Trial Designs Explained: BOIN, CRM, BLRM & Modern Adaptive Strategies

      |
        has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778891, hs_child_table_id=0, hs_updated_at=1709645745122, hs_published_at=1748379090824, description=Kurt Preugschat has over 11 years of statistical experience from Phase I to Phase IV clinical trials. He is a lead statistician, providing statistical support and oversight for numerous clinical trials associated with new drug applications (NDA), supplemental new drug applications (sNDA), and medical devices. His expertise includes the development of study designs to meet complex clinical questions and the measurement of desired outcomes. In addition, Kurt has extensive experience generating statistical analyses and creating complex SAS programs and macros used by study team., avatar=Image{width=150,height=150,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/PfMxMarkentive/authors/kurt-preugschat.webp',altText='',fileId=null}, linkedin=https://www.linkedin.com/in/kurt-preugschat-97298923a, hs_name=, hs_path=, lastname=Preugschat, hs_initial_published_at=1716136551646, hs_created_at=1709645745122, hs_is_edited=false, hs_deleted_at=0, name=Kurt, job=, slug=kurt-preugschat, email=, hs_updated_by_user_id=51739740}, second={}, third={}})
      • Kurt Preugschat avatar

        Kurt Preugschat

      Discover
    • Read: Phase I Clinical Trial Designs: Continuous Reassessment Method (CRM) Phase I Clinical Trial Designs: Continuous Reassessment Method (CRM)

      Clinical Trials

      Phase I Clinical Trial Designs: Continuous Reassessment Method (CRM)

      |
        has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778891, hs_child_table_id=0, hs_updated_at=1709645745122, hs_published_at=1748379090824, description=Kurt Preugschat has over 11 years of statistical experience from Phase I to Phase IV clinical trials. He is a lead statistician, providing statistical support and oversight for numerous clinical trials associated with new drug applications (NDA), supplemental new drug applications (sNDA), and medical devices. His expertise includes the development of study designs to meet complex clinical questions and the measurement of desired outcomes. In addition, Kurt has extensive experience generating statistical analyses and creating complex SAS programs and macros used by study team., avatar=Image{width=150,height=150,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/PfMxMarkentive/authors/kurt-preugschat.webp',altText='',fileId=null}, linkedin=https://www.linkedin.com/in/kurt-preugschat-97298923a, hs_name=, hs_path=, lastname=Preugschat, hs_initial_published_at=1716136551646, hs_created_at=1709645745122, hs_is_edited=false, hs_deleted_at=0, name=Kurt, job=, slug=kurt-preugschat, email=, hs_updated_by_user_id=51739740}, second={}, third={}})
      • Kurt Preugschat avatar

        Kurt Preugschat

      Discover
    • Read: Phase I Clinical Trial Designs: Bayesian Logistic Regression Model (BLRM) Phase I Clinical Trial Designs: Bayesian Logistic Regression Model (BLRM)

      Clinical Trials

      Phase I Clinical Trial Designs: Bayesian Logistic Regression Model (BLRM)

      |
        has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778891, hs_child_table_id=0, hs_updated_at=1709645745122, hs_published_at=1748379090824, description=Kurt Preugschat has over 11 years of statistical experience from Phase I to Phase IV clinical trials. He is a lead statistician, providing statistical support and oversight for numerous clinical trials associated with new drug applications (NDA), supplemental new drug applications (sNDA), and medical devices. His expertise includes the development of study designs to meet complex clinical questions and the measurement of desired outcomes. In addition, Kurt has extensive experience generating statistical analyses and creating complex SAS programs and macros used by study team., avatar=Image{width=150,height=150,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/PfMxMarkentive/authors/kurt-preugschat.webp',altText='',fileId=null}, linkedin=https://www.linkedin.com/in/kurt-preugschat-97298923a, hs_name=, hs_path=, lastname=Preugschat, hs_initial_published_at=1716136551646, hs_created_at=1709645745122, hs_is_edited=false, hs_deleted_at=0, name=Kurt, job=, slug=kurt-preugschat, email=, hs_updated_by_user_id=51739740}, second={}, third={}})
      • Kurt Preugschat avatar

        Kurt Preugschat

      Discover
  • Translational Research Insights

    All Translational Research Articles
    • Read: Key Strategies for Future-Proofing Gene Therapy Assays Key Strategies for Future-Proofing Gene Therapy Assays

      Translational Research - Regulatory - Assays - Gene Therapies

      Key Strategies for Future-Proofing Gene Therapy Assays

      |
        has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778875, hs_child_table_id=0, hs_updated_at=1716454216458, hs_published_at=1748379090824, description=Pharma industry veteran and expert at biomarker-driven clinical trial design and execution. Leader of biomarker and drug development programs for pharmaceutical and diagnostics companies, as well as the National Institutes of Health. Spearheaded the discovery of pharmacodynamic biomarkers and novel targets for inflammatory disease therapy., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Deb%20Phippard.webp',altText='Deb Phippard',fileId=165892372605}, linkedin=https://www.linkedin.com/in/deb-phippard-103b54, team=[{id=163072475007, name='Precision for Medicine Leadership'}], hs_name=, hs_path=, lastname=Phippard, PhD, hs_initial_published_at=1716212769184, hs_created_at=1709645745106, hs_is_edited=false, hs_deleted_at=0, name=Deborah, job= Chief Scientific Officer, slug=deborah-phippard, email=, hs_updated_by_user_id=51739740}, second={hs_id=159488778889, hs_child_table_id=0, hs_updated_at=1714461111815, hs_published_at=1748379090824, description=Travis Harrison, PhD, is Vice President of Diagnostic Development at Precision for Medicine. He brings more than 20 years of bioanalytical assay experience to the Precision team with expertise in ligand-binding and cell-based assays.  Travis has experience supporting clinical and nonclinical studies for a broad range of indications, with an emphasis on diagnostic assays to evaluate immune responses to gene therapies., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Travis%20Harrison.webp',altText='Travis Harrison',fileId=165893006481}, linkedin=https://www.linkedin.com/in/travis-harrison-phd-6108852/, hs_name=, hs_path=, lastname=Harrison, hs_initial_published_at=1716212769184, hs_created_at=1709645745120, hs_is_edited=false, hs_deleted_at=0, name=Travis, job=, slug=travis-harrison, email=, hs_updated_by_user_id=51739740}, third={}})
      • Deborah P. avatar

        Deborah P.

      • Travis H. avatar

        Travis H.

      Discover
    • Read: Gene Therapy Assays: Regulatory Compliance with Unified Immunogenicity Gene Therapy Assays: Regulatory Compliance with Unified Immunogenicity

      Translational Research - Regulatory - Assays - Gene Therapies

      Gene Therapy Assays: Regulatory Compliance with Unified Immunogenicity

      |
        has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778875, hs_child_table_id=0, hs_updated_at=1716454216458, hs_published_at=1748379090824, description=Pharma industry veteran and expert at biomarker-driven clinical trial design and execution. Leader of biomarker and drug development programs for pharmaceutical and diagnostics companies, as well as the National Institutes of Health. Spearheaded the discovery of pharmacodynamic biomarkers and novel targets for inflammatory disease therapy., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Deb%20Phippard.webp',altText='Deb Phippard',fileId=165892372605}, linkedin=https://www.linkedin.com/in/deb-phippard-103b54, team=[{id=163072475007, name='Precision for Medicine Leadership'}], hs_name=, hs_path=, lastname=Phippard, PhD, hs_initial_published_at=1716212769184, hs_created_at=1709645745106, hs_is_edited=false, hs_deleted_at=0, name=Deborah, job= Chief Scientific Officer, slug=deborah-phippard, email=, hs_updated_by_user_id=51739740}, second={hs_id=159488778840, hs_child_table_id=0, hs_updated_at=1716132440837, hs_published_at=1748379090824, description=Maham Ansari, MS, RAC is a Senior Director, IVD Regulatory Affairs. Her focus is on companion diagnostic co-development programs, where she leverages her regulatory expertise to secure approvals in the US, Europe and beyond for companion diagnostics with a specific focus on gene therapy. She brings more than 16 years of global regulatory leadership experience in the medical device and in vitro diagnostics industry, spanning major multinationals to small start-ups, including full life cycle management across all stages of product development, execution of global regulatory strategies, and post-market surveillance.sh, avatar=Image{width=710,height=710,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Maham_Ansari.png',altText='Maham_Ansari',fileId=167373022876}, linkedin=https://www.linkedin.com/in/maham-ansari-ms-rac-6a735739, hs_name=, hs_path=, lastname=Ansari, hs_initial_published_at=1716212769184, hs_created_at=1709645745071, hs_is_edited=false, hs_deleted_at=0, name=Maham, job=, slug=maham-ansari, email=, hs_updated_by_user_id=51739740}, third={}})
      • Deborah P. avatar

        Deborah P.

      • Maham A. avatar

        Maham A.

      Discover
    • Read: Optimizing Immunohistochemistry Validation and Regulatory Strategies Optimizing Immunohistochemistry Validation and Regulatory Strategies

      Translational Research - Biomarkers - Assays

      Optimizing Immunohistochemistry Validation and Regulatory Strategies

      |
        has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778874, hs_child_table_id=0, hs_updated_at=1714461729999, hs_published_at=1748379090824, description=Kennon Daniels is a scientific and regulatory in vitro diagnostic authority, specializing in the development of US regulatory strategies and FDA marketing submissions for IVD assays and instruments. Her expertise spans all aspects of product development, analytical and clinical trial protocol designs, Q-Submissions, IDEs, de novos, 510(k)s, and pre-market approval platforms., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Kennon%20Daniels.webp',altText='Kennon Daniels',fileId=165893120790}, linkedin=https://www.linkedin.com/in/kennon-daniels-ph-d-84a90b6, hs_name=, hs_path=, lastname=Daniels, hs_initial_published_at=1716212769184, hs_created_at=1709645745105, hs_is_edited=false, hs_deleted_at=0, name=Kennon, job=, slug=kennon-daniels, email=, hs_updated_by_user_id=51739740}, second={hs_id=182710436924, hs_child_table_id=0, hs_updated_at=1731419754428, hs_published_at=1748379090824, description=Christie Bongel, MS, CT(ASCP), brings nearly two decades of experience in both research and clinical medicine. As the site director for Precision for Medicine’s IHC Center of Excellence in North Carolina, she excels in managing scientific operations and collaborating with clients. Christie is skilled in cytology, laboratory medicine, and molecular diagnostics. Her role focuses on building an energized team dedicated to delivering life-changing outcomes for patients. Christie earned her MS in Applied Biotechnology and is an ASCP certified cytotechnologist., avatar=Image{width=260,height=260,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Christie%20Bongel_Square_260px.jpg',altText='Christie Bongel_Square_260px',fileId=178044303113}, lastname= Bongel, hs_initial_published_at=1731517828480, hs_created_by_user_id=28386183, hs_created_at=1731419696820, hs_is_edited=false, hs_deleted_at=0, name=Christie, job=Site Director - Histology, slug=christie-bongel, hs_updated_by_user_id=51739740}, third={}})
      • Kennon D. avatar

        Kennon D.

      • Christie  . avatar

        Christie .

      Discover

All articles

  • Read: Lessons Learned from a Rare Pediatric Case Study Lessons Learned from a Rare Pediatric Case Study

    Rare Diseases

    Lessons Learned from a Rare Pediatric Case Study

    |
      has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778894, hs_child_table_id=0, hs_updated_at=1714461151531, hs_published_at=1748379090824, description=Vincent Shortino is a Principal Clinical Trial Manager, bringing more than 20 years of experience to Precision. His experience spans all major therapeutic areas with a heavy emphasis on Cardiovascular and Rare Indications, across Phases I–IV. He brings solid perspectives inclusive of sites, pharma and CROs from his previous roles of Study Coordinator, Site Director, CRA, and Clinical Trial Manager., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Vincent%20Shortino.webp',altText='Vincent Shortino',fileId=165892429964}, linkedin=https://www.linkedin.com/in/vincent-shortino-954b3857, team=[{id=163080551773, name='Clinical Solutions Leadership'}], hs_name=, hs_path=, lastname=Shortino, hs_initial_published_at=1716212769184, hs_created_at=1709645745125, hs_is_edited=false, hs_deleted_at=0, name=Vincent, job=Principal Clinical Trial Manager, slug=vincent-shortino, email=, hs_updated_by_user_id=51739740}, second={}, third={}})
    • Vincent Shortino avatar

      Vincent Shortino

    Discover
  • Read: Optimizing Investigator Databases for Oncology Trial Enrollment Investigator Databases for Oncology Trial Enrollment

    Clinical Trials - Oncology

    Optimizing Investigator Databases for Oncology Trial Enrollment

    |
      has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778894, hs_child_table_id=0, hs_updated_at=1714461151531, hs_published_at=1748379090824, description=Vincent Shortino is a Principal Clinical Trial Manager, bringing more than 20 years of experience to Precision. His experience spans all major therapeutic areas with a heavy emphasis on Cardiovascular and Rare Indications, across Phases I–IV. He brings solid perspectives inclusive of sites, pharma and CROs from his previous roles of Study Coordinator, Site Director, CRA, and Clinical Trial Manager., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Vincent%20Shortino.webp',altText='Vincent Shortino',fileId=165892429964}, linkedin=https://www.linkedin.com/in/vincent-shortino-954b3857, team=[{id=163080551773, name='Clinical Solutions Leadership'}], hs_name=, hs_path=, lastname=Shortino, hs_initial_published_at=1716212769184, hs_created_at=1709645745125, hs_is_edited=false, hs_deleted_at=0, name=Vincent, job=Principal Clinical Trial Manager, slug=vincent-shortino, email=, hs_updated_by_user_id=51739740}, second={}, third={}})
    • Vincent Shortino avatar

      Vincent Shortino

    Discover
  • Read: Inside a CRO: The Pivotal Role of Clinical Trial Manager in Clinical Research Inside a CRO - The Pivotal Role of Clinical Trial Manager in Clinical Research

    Clinical Trials

    Inside a CRO: The Pivotal Role of Clinical Trial Manager in Clinical Research

    |
      has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778894, hs_child_table_id=0, hs_updated_at=1714461151531, hs_published_at=1748379090824, description=Vincent Shortino is a Principal Clinical Trial Manager, bringing more than 20 years of experience to Precision. His experience spans all major therapeutic areas with a heavy emphasis on Cardiovascular and Rare Indications, across Phases I–IV. He brings solid perspectives inclusive of sites, pharma and CROs from his previous roles of Study Coordinator, Site Director, CRA, and Clinical Trial Manager., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Vincent%20Shortino.webp',altText='Vincent Shortino',fileId=165892429964}, linkedin=https://www.linkedin.com/in/vincent-shortino-954b3857, team=[{id=163080551773, name='Clinical Solutions Leadership'}], hs_name=, hs_path=, lastname=Shortino, hs_initial_published_at=1716212769184, hs_created_at=1709645745125, hs_is_edited=false, hs_deleted_at=0, name=Vincent, job=Principal Clinical Trial Manager, slug=vincent-shortino, email=, hs_updated_by_user_id=51739740}, second={}, third={}})
    • Vincent Shortino avatar

      Vincent Shortino

    Discover
  • Read: Decentralized Clinical Trials: Strategies that Work in Rare Diseases Decentralized Clinical Trials

    Clinical Trials - Rare Diseases

    Decentralized Clinical Trials: Strategies that Work in Rare Diseases

    |
      has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778894, hs_child_table_id=0, hs_updated_at=1714461151531, hs_published_at=1748379090824, description=Vincent Shortino is a Principal Clinical Trial Manager, bringing more than 20 years of experience to Precision. His experience spans all major therapeutic areas with a heavy emphasis on Cardiovascular and Rare Indications, across Phases I–IV. He brings solid perspectives inclusive of sites, pharma and CROs from his previous roles of Study Coordinator, Site Director, CRA, and Clinical Trial Manager., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Vincent%20Shortino.webp',altText='Vincent Shortino',fileId=165892429964}, linkedin=https://www.linkedin.com/in/vincent-shortino-954b3857, team=[{id=163080551773, name='Clinical Solutions Leadership'}], hs_name=, hs_path=, lastname=Shortino, hs_initial_published_at=1716212769184, hs_created_at=1709645745125, hs_is_edited=false, hs_deleted_at=0, name=Vincent, job=Principal Clinical Trial Manager, slug=vincent-shortino, email=, hs_updated_by_user_id=51739740}, second={}, third={}})
    • Vincent Shortino avatar

      Vincent Shortino

    Discover
  • Read: Phase 1/2 Combination Studies: Best Practices When Moving from Escalation to Expansion Combination Studies

    Clinical Trials - Early Phase Research - Oncology

    Phase 1/2 Combination Studies: Best Practices When Moving from Escalation to Expansion

    |
      has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778894, hs_child_table_id=0, hs_updated_at=1714461151531, hs_published_at=1748379090824, description=Vincent Shortino is a Principal Clinical Trial Manager, bringing more than 20 years of experience to Precision. His experience spans all major therapeutic areas with a heavy emphasis on Cardiovascular and Rare Indications, across Phases I–IV. He brings solid perspectives inclusive of sites, pharma and CROs from his previous roles of Study Coordinator, Site Director, CRA, and Clinical Trial Manager., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Vincent%20Shortino.webp',altText='Vincent Shortino',fileId=165892429964}, linkedin=https://www.linkedin.com/in/vincent-shortino-954b3857, team=[{id=163080551773, name='Clinical Solutions Leadership'}], hs_name=, hs_path=, lastname=Shortino, hs_initial_published_at=1716212769184, hs_created_at=1709645745125, hs_is_edited=false, hs_deleted_at=0, name=Vincent, job=Principal Clinical Trial Manager, slug=vincent-shortino, email=, hs_updated_by_user_id=51739740}, second={}, third={}})
    • Vincent Shortino avatar

      Vincent Shortino

    Discover
  • Read: Shifting the Paradigm in Personalized Medicine Clinical Trials Personalized Medicine Clinical Trials

    Clinical Trials - Biomarkers

    Shifting the Paradigm in Personalized Medicine Clinical Trials

    |
      has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778894, hs_child_table_id=0, hs_updated_at=1714461151531, hs_published_at=1748379090824, description=Vincent Shortino is a Principal Clinical Trial Manager, bringing more than 20 years of experience to Precision. His experience spans all major therapeutic areas with a heavy emphasis on Cardiovascular and Rare Indications, across Phases I–IV. He brings solid perspectives inclusive of sites, pharma and CROs from his previous roles of Study Coordinator, Site Director, CRA, and Clinical Trial Manager., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Vincent%20Shortino.webp',altText='Vincent Shortino',fileId=165892429964}, linkedin=https://www.linkedin.com/in/vincent-shortino-954b3857, team=[{id=163080551773, name='Clinical Solutions Leadership'}], hs_name=, hs_path=, lastname=Shortino, hs_initial_published_at=1716212769184, hs_created_at=1709645745125, hs_is_edited=false, hs_deleted_at=0, name=Vincent, job=Principal Clinical Trial Manager, slug=vincent-shortino, email=, hs_updated_by_user_id=51739740}, second={}, third={}})
    • Vincent Shortino avatar

      Vincent Shortino

    Discover
  • Read: Rare Disease CNS Study Delivers On-Time Results During Pandemic Rare Disease CNS Study Delivers On-Time Results During Pandemic

    Clinical Trials - Rare Diseases

    Rare Disease CNS Study Delivers On-Time Results During Pandemic

    |
      has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778894, hs_child_table_id=0, hs_updated_at=1714461151531, hs_published_at=1748379090824, description=Vincent Shortino is a Principal Clinical Trial Manager, bringing more than 20 years of experience to Precision. His experience spans all major therapeutic areas with a heavy emphasis on Cardiovascular and Rare Indications, across Phases I–IV. He brings solid perspectives inclusive of sites, pharma and CROs from his previous roles of Study Coordinator, Site Director, CRA, and Clinical Trial Manager., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Vincent%20Shortino.webp',altText='Vincent Shortino',fileId=165892429964}, linkedin=https://www.linkedin.com/in/vincent-shortino-954b3857, team=[{id=163080551773, name='Clinical Solutions Leadership'}], hs_name=, hs_path=, lastname=Shortino, hs_initial_published_at=1716212769184, hs_created_at=1709645745125, hs_is_edited=false, hs_deleted_at=0, name=Vincent, job=Principal Clinical Trial Manager, slug=vincent-shortino, email=, hs_updated_by_user_id=51739740}, second={}, third={}})
    • Vincent Shortino avatar

      Vincent Shortino

    Discover
Loading...
You've reach the end